MicroRNAs and Alu elements in the p53-Mdm2-Mdm4 regulatory network

Journal of Molecular Cell Biology

Volumn 6, Issue 3, 2014, Pages 192-197

  Hoffman, Yonit ^a   Pilpel, Yitzhak ^a   Oren, Moshe ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Alu; Mdm2; Mdm4; microRNA; p53

Indexed keywords

MESSENGER RNA; MICRORNA; PROTEIN MDM2; PROTEIN MDMX; PROTEIN P53; SMALL UNTRANSLATED RNA; NUCLEAR PROTEIN;

3' UNTRANSLATED REGION; ALU SEQUENCE; GENE CONTROL; GENE FUNCTION; GENE REGULATORY NETWORK; HUMAN; HUMAN GENOME; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR BIOLOGY; NONHUMAN; PATHOLOGY; PROTEIN FUNCTION; REGULATORY MECHANISM; RETROPOSON; REVIEW; ANIMAL; GENETICS; METABOLISM;

ALU ELEMENTS; ANIMALS; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84901716006     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mju020     Document Type: Review

References (66)

1. ′ untranslated regions. BMC Genomics 5, 97.
2. Bailey, J. A., Liu, G., and Eichler, E. E. (2003). An Alu transposition model for the origin and expansion of human segmental duplications. Am. J. Hum. Genet. 73, 823-834. (Pubitemid 37271886)
3. Barak, Y., Juven, T., Haffner, R., et al. (1993). mdm2expressionisinducedbywild type p53 activity. EMBO J. 12, 461-468.
4. Barboza, J. A., Iwakuma, T., Terzian, T., et al. (2008). Mdm2 and Mdm4 loss regulates distinct p53 activities. Mol. Cancer Res. 6, 947-954.
5. Bartel, D. P. (2009). MicroRNAs: targetrecognition and regulatory functions. Cell 136, 215-233.
6. Brady, C. A., andAttardi, L. D. (2010). p53ataglance. J. Cell Sci. 123, 2527-2532.
7. Braun, C. J., Zhang, X., Savelyeva, I., et al. (2008). p53-Responsive microRNAs 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 68, 10094-10104.
8. Dahary, D., Shalgi, R., and Pilpel, Y. (2011). CpG Islands as a putative source for animal miRNAs: evolutionary and functional implications. Mol. Biol. Evol. 28, 1545-1551.
9. Dar, A. A., Majid, S., Rittsteuer, C., et al. (2013). TheroleofmiR-18binMDM2-p53 pathway signaling and melanoma progression. J. Natl Cancer Inst. 105, 433-442.
10. Dewannieux, M., Esnault, C., and Heidmann, T. (2003). LINE-mediated retrotran-sposition of marked Alu sequences. Nat. Genet. 35, 41-48. (Pubitemid 37048594)
11. Dolezelova, H., and Slampa, P. (2007). The impact of positron emission tomography in the radiotherapy treatment planning. Minireview. Neoplasma 54, 95-100.
12. Georges, S. A., Biery, M. C., Kim, S. Y., et al. (2008). Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Res. 68, 10105-10112.
13. Grimson, A., Farh, K. K., Johnston, W. K., et al. (2007). MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105. (Pubitemid 46991392)
14. Haupt, Y., Maya, R., Kazaz, A., et al. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299. (Pubitemid 27220766)
15. Hermeking, H. (2010). The miR-34 family in cancer and apoptosis. Cell Death Differ. 17, 193-199.
16. Hoffman, Y., Dahary, D., Bublik, D. R., et al. (2013). The majority of endogenous microRNA targets within Alu elements avoid the microRNA machinery. Bioinformatics 29, 894-902.
17. Hoffman, Y., Bublik, D. R., Pilpel, Y., et al. (2014). miR-661 downregulates both Mdm2 and Mdm4 to activate p53. Cell Death Differ. 21, 302-309.
18. Honda, R., Tanaka, H., and Yasuda, H. (1997). Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420, 25-27. (Pubitemid 28037193)
19. Huang, Y., Chuang, A., Hao, H., et al. (2011a). Phospho-DeltaNp63alpha is akey regulator of the cisplatin-induced microRNAome in cancer cells. Cell Death Differ. 18, 1220-1230.
20. Huang, Y., Chuang, A. Y., and Ratovitski, E. A. (2011b). Phospho-DeltaNp63alpha/miR-885-3p axis in tumor cell life and cell death upon cis-platin exposure. Cell Cycle 10, 3938-3947.
21. Hunten, S., Siemens, H., Kaller, M., et al. (2013). The p53/microRNA network in cancer: experimental and bioinformatics approaches. Adv. Exp. Med. Biol. 774, 77-101.
22. Juven, T., Barak, Y., Zauberman, A., et al. (1993). Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene. Oncogene 8, 3411-3416. (Pubitemid 23342640)
23. Khella, H. W., Bakhet, M., Allo, G., et al. (2013). miR-192, miR-194 and miR-215:a convergent microRNA network suppressing tumor progression in renal cell carcinoma. Carcinogenesis 34, 2231-2239.
24. Kim, D., Song, J., and Jin, E. J. (2010). MicroRNA-221 regulates chondrogenic differentiation through promoting proteosomal degradationof slugbytargeting Mdm2. J. Biol. Chem. 285, 26900-26907.
25. Krell, J., Frampton, A. E., Colombo, T., et al. (2013). The p53 miRNA interactome and its potential role in the cancer clinic. Epigenomics 5, 417-428.
26. Kubbutat, M. H., Jones, S. N., and Vousden, K. H. (1997). Regulation ofp53 stability by Mdm2. Nature 387, 299-303.
27. Lander, E. S., Linton, L. M., Birren, B., et al. (2001). Initial sequencing and analysis of the human genome. Nature 409, 860-921. (Pubitemid 32165345)
28. Lehnert, S., Van Loo, P., Thilakarathne, P. J., et al. (2009). Evidence for co-evolution between human microRNAs and Alu-repeats. PLoS One 4, e4456.
29. Lenos, K., and Jochemsen, A. G. (2011). Functions of MDMX in the modulation of the p53-response. J. Biomed. Biotechnol. 2011, 876173.
30. ′ splice-site selection in Alu exons. Science 300, 1288-1291. (Pubitemid 36618239)
31. Levine, A. J., and Oren, M. (2009). The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer 9, 749-758.
32. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20. (Pubitemid 40094598)
33. Li, H., and Yang, B. B. (2012). Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2. Oncotarget 3, 1653-1668.
34. Li, Y., Gao, L., Luo, X., et al. (2013). Epigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathway. Blood 121, 499-509.
35. Linares, L. K., Hengstermann, A., Ciechanover, A., et al. (2003). HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53. Proc. Natl Acad. Sci. USA 100, 12009-12014. (Pubitemid 37271506)
36. Mancini, F., DiConza, G., Pellegrino, M., et al. (2009). MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. EMBO J. 28, 1926-1939.
37. Mandke, P., Wyatt, N., Fraser, J., et al. (2012). MicroRNA-34a modulates MDM4 expression via a target site in the open reading frame. PLoS One 7, e42034.
38. McEvoy, J., Ulyanov, A., Brennan, R., et al. (2012). Analysis of MDM2 and MDM4 single nucleotide polymorphisms, mRNA splicing and protein expression in retinoblastoma. PLoS One 7, e42739.
39. Oliner, J. D. (1993). Discerning the function of p53 by examining its molecular interactions. Bioessays 15, 703-707. (Pubitemid 2010114)
40. Ovcharenko, D., Stolzel, F., Poitz, D., et al. (2011). miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia. Exp. Hematol. 39, 1030-1042. e7.
41. Pereg, Y., Shkedy, D., de Graaf, P., et al. (2005). Phosphorylation of Hdmx mediates its Hdm2-and ATM-dependent degradationinresponsetoDNA damage. Proc. Natl Acad. Sci. USA 102, 5056-5061.
42. Pichiorri, F., Suh, S. S., Rocci, A., et al. (2010). Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 18, 367-381.
43. Piriyapongsa, J., Marino-Ramirez, L., and Jordan, I. K. (2007). Origin and evolution of human microRNAsfrom transposable elements. Genetics 176, 1323-1337. (Pubitemid 46961124)
44. Polak, P., and Domany, E. (2006). Alu elements contain many binding sites for transcription factors and may play a role in regulation of developmental processes. BMC Genomics 7, 133.
45. Poyurovsky, M. V., and Prives, C. (2006). Unleashing the power of p53: lessons from mice and men. Genes Dev. 20, 125-131. (Pubitemid 43112930)
46. Reyes-Herrera, P. H., and Ficarra, E. (2012). One decade of development and evolution of microRNA target prediction algorithms. Genomics Proteomics Bioinformatics 10, 254-263.
47. Shalgi, R., Pilpel, Y., and Oren, M. (2010). Repression of transposable-elements-a microRNA anti-cancer defense mechanism? Trends Genet. 26, 253-259.
48. Sharp, D. A., Kratowicz, S. A., Sank, M. J., et al. (1999). Stabilization of the MDM2 oncoproteinbyinteraction with the structurally related MDMX protein. J. Biol. Chem. 274, 38189-38196. (Pubitemid 30026893)
49. Sinnett, D., Richer, C., Deragon, J. M., et al. (1991). Alu RNA secondary structure consists of two independent 7 SL RNA-like folding units. J. Biol. Chem. 266, 8675-8678. (Pubitemid 21906565)
50. Smalheiser, N. R., and Torvik, V. I. (2005). Mammalian microRNAs derived from genomic repeats. Trends Genet. 21, 322-326. (Pubitemid 40726387)
51. Smalheiser, N. R., and Torvik, V. I. (2006). Alu elements within human mRNAs are probable microRNA targets. Trends Genet. 22, 532-536. (Pubitemid 44374128)
52. Sood, P., Krek, A., Zavolan, M., et al. (2006). Cell-type-specific signatures of microRNAs on target mRNA expression. Proc. Natl Acad. Sci. USA 103, 2746-2751.
53. Spengler, R. M., Oakley, C. K., and Davidson, B. L. (2014). Functional microRNAs and target sites are created by lineage-specific transposition. Hum. Mol. Genet. 23, 1783-1793.
54. Stommel, J. M., and Wahl, G. M. (2004). Accelerated MDM2 auto-degradation induced by DNA-damage kinases is required for p53 activation. EMBO J. 23, 1547-1556. (Pubitemid 38579515)
55. Subtelny, A. O., Eichhorn, S. W., Chen, G. R., et al. (2014). Poly(A)-tail profiling reveals an embryonic switch in translational control. Nature 508, 66-71.
56. Suh, S. S., Yoo, J. Y., Nuovo, G. J., et al. (2012). MicroRNAs/TP53 feedbackcircuitry in glioblastoma multiforme. Proc. Natl Acad. Sci. USA 109, 5316-5321.
57. Thut, C. J., Goodrich, J. A., and Tjian, R. (1997). Repression of p53-mediated transcription by MDM2: a dual mechanism. Genes Dev. 11, 1974-1986. (Pubitemid 27332984)
58. Uldrijan, S., Pannekoek, W. J., and Vousden, K. H. (2007). An essential function of the extreme C-terminus of MDM2 can be provided by MDMX. EMBO J. 26, 102-112. (Pubitemid 46094703)
59. Wade, M., Li, Y. C., and Wahl, G. M. (2013). MDM2, MDMX andp53inoncogenesis and cancer therapy. Nat. Rev. Cancer 13, 83-96.
60. Wang, M., Gu, H., Qian, H., et al. (2013). miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation. Eur. J. Cancer 49, 2010-2021.
61. Wu, X., Bayle, J. H., Olson, D., et al. (1993). The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 7, 1126-1132. (Pubitemid 23207405)
62. ′ UTR of MDM4 affects ovarian cancer progression and chemosensitivity. Cancer Res. 70, 9641-9649.
63. Xiao, J., Lin, H., Luo, X., et al. (2011). miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress. EMBO J. 30, 5021.
64. Yuan, Z., Sun, X., Jiang, D., et al. (2010). Origin and evolution of a placental-specific microRNA family in the human genome. BMC Evol. Biol. 10, 346.
65. Zambetti, G. P., and Levine, A. J. (1993). A comparison of the biological activities of wild-type and mutant p53. FASEB J. 7, 855-865. (Pubitemid 23225541)
66. Zhang, J., Sun, Q., Zhang, Z., et al. (2013). Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene 32, 61-69.